Featured Research

from universities, journals, and other organizations

'Ephedra-free' Dietary Supplements Pose Potential Health Risks

Date:
September 9, 2005
Source:
University of California - San Francisco
Summary:
Two common weight loss supplements promoted as ephedra-free and safe for dieters caused increased heart rate among healthy people, and could have harmful health effects in some people, according to a study by UCSF scientists. Their placebo-controlled clinical study is the first to examine the pharmacological effects of these re-formulated dietary supplements.

Two common weight loss supplements promoted as ephedra-free and safefor dieters caused increased heart rate among healthy people, and couldhave harmful health effects in some people, according to a study byUCSF scientists. Their placebo-controlled clinical study is the firstto examine the pharmacological effects of these re-formulated dietarysupplements.

The research examined the effects on blood pressure and heart rateof two dietary supplements containing bitter orange extract -- asubstance that has rapidly replaced ephedra in weight-loss productssince it was banned by the FDA in 2004 because of concerns aboutserious health effects.

The study involved 10 healthy adults given single doses of oneof the two supplements or a placebo. The two supplements tested wereAdvantra Z and Xenadrine EFX. Single doses of both products increasedheart rate by an average of 11 to 16 beats per minute over baseline,the scientists found. This would be the equivalent of an 18 percentincrease if baseline rate is 80 beats per minute.

In addition, Xenadrine EFX also significantly increased bloodpressure by 7 to 12 percent (9-10 mm Hg), the researchers reported.Xenadrine EFX appears to have similar acute cardiovascular stimulantactions as banned ephedra products, according to their report.

"These findings indicate that ephedra-free dietary supplementscould have some of the same adverse health effects associated withpreviously available ephedra products, such as Metabolife 356 andRipped Fuel," said Christine Haller, MD, UCSF assistant professor ofmedicine and lead author of the paper.

The scientists call for further research on the safety andeffectiveness of bitter orange- containing supplements -- particularlyamong those most likely to take them: overweight people who may haveother health conditions.

The research is published in the September issue of The American Journal of Medicine, available September 9.

Bitter orange extract, or Citrus aurantium, is extracted fromthe dried fruit peel of bitter orange. Known in Chinese herbal medicineas Zhi shi, it is a traditional remedy for gastrointestinal ailments,the scientists said.

The predominant constituent of bitter orange is synephrine,which in pharmaceutical form is commonly used to treat low bloodpressure and nasal congestion.

Advantra Z contains only bitter orange, while one dose ofXenadrine EFX contains several other ingredients, including caffeineequivalent to the amount in 3 cups of coffee, the researchers found.The increased blood pressure from taking Xenadrine EFX is likely notdue to caffeine alone, they concluded, but potentially related to theactions or interaction of other constituents in the multi-ingredientsupplement.

The scientists call for longer term dosing studies to determinewhether the blood pressure effects of Xenadrine EFX persist withrepeated use. Until such data are available, they conclude, doctorsshould caution patients about using ephedra-free weight-loss dietarysupplements and should monitor blood pressure in those who choose touse the products.

In particular, people with hypertension, heart disease or otherpre-existing conditions that could be aggravated by the supplementsshould avoid them.

"Consumers should be aware that ephedra-free dietarysupplements have not been extensively tested for safety and the healtheffects are not well known," Haller noted.

Among other physiological measures, heart rate and bloodpressure were recorded in the study for an hour before dosing and thenat several intervals afterwards.

To rate physical symptoms, moods and emotions, questionnaireswere administered one, two and six hours six hours after taking thesupplements or placebo.

The caffeine-containing Xenadrine EFX product also increasedalertness according to responses on the questionnaire. But neitherproduct appears to have a significant effect on mood, the study found.

Co-authors on the study with Haller were Neal Benowitz, MD,professor of medicine and of clinical pharmacy at UCSF, and PeytonJacob III, PhD, a researcher in psychiatry at UCSF.

###

The research is funded by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University of California - San Francisco. "'Ephedra-free' Dietary Supplements Pose Potential Health Risks." ScienceDaily. ScienceDaily, 9 September 2005. <www.sciencedaily.com/releases/2005/09/050909074252.htm>.
University of California - San Francisco. (2005, September 9). 'Ephedra-free' Dietary Supplements Pose Potential Health Risks. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2005/09/050909074252.htm
University of California - San Francisco. "'Ephedra-free' Dietary Supplements Pose Potential Health Risks." ScienceDaily. www.sciencedaily.com/releases/2005/09/050909074252.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins